Publication:

The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury

Date

Date

Date
2022
Journal Article
Published version

Citations

Citation copied

Akeret, K., Buzzi, R. M., Saxenhofer, M., Bieri, K., Chiavi, D., Thomson, B. R., Grüttner-Durmaz, M., Schwendinger, N., Humar, R., Regli, L., van Doormaal, T. P. C., Held, U., Keller, E., Hugelshofer, M., Schaer, D. J., & et al. (2022). The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury. BMC Neurology, 22, 267. https://doi.org/10.1186/s12883-022-02789-w

Abstract

Abstract

Abstract

Introduction: Preclinical studies provided a strong rationale for a pathophysiological link between cell-free hemoglobin in the cerebrospinal fluid (CSF-Hb) and secondary brain injury after subarachnoid hemorrhage (SAH-SBI). In a single-center prospective observational clinical study, external ventricular drain (EVD) based CSF-Hb proved to be a promising biomarker to monitor for SAH-SBI. The primary objective of the HeMoVal study is to prospectively validate the association between EVD based CSF-Hb and SAH-SBI during the first 14 days

Metrics

Downloads

58 since deposited on 2022-10-11
Acq. date: 2025-11-13

Views

113 since deposited on 2022-10-11
Acq. date: 2025-11-13

Additional indexing

Creators (Authors)

  • Akeret, Kevin
    affiliation.icon.alt
  • Saxenhofer, Moritz
    affiliation.icon.alt
  • Bieri, Kathrin
    affiliation.icon.alt
  • Chiavi, Deborah
    affiliation.icon.alt
  • Thomson, Bart R
    affiliation.icon.alt
  • Grüttner-Durmaz, Manuela
    affiliation.icon.alt
  • Schwendinger, Nina
    affiliation.icon.alt
  • Humar, Rok
    affiliation.icon.alt
  • Regli, Luca
    affiliation.icon.alt
  • van Doormaal, Tristan P C
    affiliation.icon.alt
  • Held, Ulrike
    affiliation.icon.alt
  • Hugelshofer, Michael
    affiliation.icon.alt
  • Schaer, Dominik J
    affiliation.icon.alt
  • et al

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
22

Page range/Item number

Page range/Item number

Page range/Item number
267

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Keywords

Neurology (clinical), General Medicine

Language

Language

Language
English

Publication date

Publication date

Publication date
2022-12-01

Date available

Date available

Date available
2022-10-11

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
1471-2377

OA Status

OA Status

OA Status
Gold

Free Access at

Free Access at

Free Access at
Pubmed ID

PubMed ID

PubMed ID

PubMed ID

Metrics

Downloads

58 since deposited on 2022-10-11
Acq. date: 2025-11-13

Views

113 since deposited on 2022-10-11
Acq. date: 2025-11-13

Citations

Citation copied

Akeret, K., Buzzi, R. M., Saxenhofer, M., Bieri, K., Chiavi, D., Thomson, B. R., Grüttner-Durmaz, M., Schwendinger, N., Humar, R., Regli, L., van Doormaal, T. P. C., Held, U., Keller, E., Hugelshofer, M., Schaer, D. J., & et al. (2022). The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury. BMC Neurology, 22, 267. https://doi.org/10.1186/s12883-022-02789-w

Gold Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image